L. Gibbons

发表

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration

D. Neary, D. Mann, J. Snowden, 2008, Acta Neuropathologica.

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.

M. Nalls, A. Singleton, T. Wolfsberg, 2013, JAMA neurology.

Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.

D. Neary, D. Mann, S. Rollinson, 2012, Brain : a journal of neurology.

Multisystem inflammatory syndrome in children

L. Gibbons, K. Xuereb, A. Greenway, 2021, Nursing.

No Association Between Cholinergic Muscarinic Receptor 2 (CHRM2) Genetic Variation and Cognitive Abilities in Three Independent Samples

Timothy C. Bates, R. Marioni, I. Deary, 2009, Behavior genetics.

Influence and interactions of cathepsin D, HLA‐DRB1 and APOE on cognitive abilities in an older non‐demented population

P. Rabbitt, Jane Worthington, A. Payton, 2006, Genes, brain, and behavior.

Cognitive Phenotypes in Alzheimer's Disease and Genetic Risk

Julie S. Snowden, D. Neary, D. Mann, 2007, Cortex.

Genetic associations between cathepsin D exon 2 C→T polymorphism and Alzheimer’s disease, and pathological correlations with genotype

D. Neary, D. Mann, C. Lendon, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Cathepsin D exon 2 polymorphism associated with general intelligence in a healthy older population

P. Diggle, P. Rabbitt, Jane Worthington, 2003, Molecular Psychiatry.

Influence of serotonin transporter gene polymorphisms on cognitive decline and cognitive abilities in a nondemented elderly population

A. Pickles, P. Rabbitt, Jane Worthington, 2005, Molecular Psychiatry.

Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: comment on the article by Wessels et al.

R. Warren, L. Gibbons, 2008, Arthritis & Rheumatism.

Apolipoprotein E υ4 Allele Frequency in Vascular Dementia

D. Mann, A. Burns, A. Payton, 2006, Dementia and Geriatric Cognitive Disorders.

Apolipoprotein E epsilon4 allele frequency in vascular dementia.

D. Mann, A. Burns, A. Payton, 2006, Dementia and geriatric cognitive disorders.

Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease

D. Neary, S. Rollinson, A. Richardson, 2012, Neurobiology of Aging.

Distinct clinical characteristics in patients with frontotemporal dementia and C9ORF72 mutations: a study of demographics, neurology, behaviour, cognition and histopathology

D. Neary, S. Rollinson, J. Snowden, 2012 .

CELL MAINTENANCE AND STRESS RESPONSE IN AGEING AND LONGEVITY

T. Kirkwood, A. Kowald, P. Kapahi, 1996 .

Deletion/Insertion Polymorphism of the Angiotensin‐Converting Enzyme Gene and White Matter Hyperintensities in Dementia: A Pilot Study

C. McCollum, A. Burns, R. O. Oude Voshaar, 2006, Journal of the American Geriatrics Society.

Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration

D. Neary, D. Mann, S. Rollinson, 2015, Neurobiology of Aging.

Apolipoprotein E ε4 Allele Frequency and Age at Onset of Alzheimer’s Disease

D. Neary, D. Mann, A. Burns, 2006, Dementia and Geriatric Cognitive Disorders.

The apolipoprotein E ε4 allele selectively increases the risk of frontotemporal lobar degeneration in males

D. Neary, D. Mann, A. Varma, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.

M. Nalls, A. Singleton, T. Wolfsberg, 2013, JAMA neurology.